CLO25-101: Cost-Effectiveness of Dose Reduction of Antibody-Drug Conjugates for Breast Cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	23
Issue number	35
DOIs	https://doi.org/10.6004/jnccn.2024.7117
State	Published - Mar 28 2025

Access to Document

@article{55ffabb863ca42499e8023b28ba6ed6e,

title = "CLO25-101: Cost-Effectiveness of Dose Reduction of Antibody-Drug Conjugates for Breast Cancer",

author = "Gabrielle Librizzi and Jules Cohen",

year = "2025",

month = mar,

day = "28",

doi = "10.6004/jnccn.2024.7117",

language = "English",

volume = "23",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "35",

}

TY - JOUR

T1 - CLO25-101

T2 - Cost-Effectiveness of Dose Reduction of Antibody-Drug Conjugates for Breast Cancer

AU - Librizzi, Gabrielle

AU - Cohen, Jules

PY - 2025/3/28

Y1 - 2025/3/28

UR - https://www.scopus.com/pages/publications/105002490186

U2 - 10.6004/jnccn.2024.7117

DO - 10.6004/jnccn.2024.7117

M3 - Article

C2 - 40154304

SN - 1540-1405

VL - 23

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 35

ER -